Leukemias: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for adults with leukemia. To learn more about a study, choose from the list below.

For clinical trials for children with leukemia, please visit Pediatric Clinical Trials.

You can also visit our Blood & Marrow Stem Cell Transplantation Clinical Trials.

Showing 33 trials
Title Investigator
A Phase I Study of AC220 plus Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
[Protocol 11-160] 		Tallman, Martin, MD
A Phase I Study of BI 836858 in Patients with Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-133] 		Tallman, Martin, MD
A Phase I Study of BMS-906024 in Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
[Protocol 11-181] 		Douer, Dan, MD
A Phase I Study of BMS-936558 in Patients with Relapsed or Refractory Hematologic Cancers
[Protocol 12-142] 		Lesokhin, Alexander, MD
A Phase I Study of Consolidation Therapy with Autologous T Cells Genetically Targeted to CD19 in Patients with Chronic Lymphocytic Leukemia After Initial Chemotherapy
[Protocol 11-048] 		Park, Jae, MD
A Phase I Study of EPZ-5676 in Patients with Relapsed/Refractory Leukemia and Other Advanced Hematologic Cancers
[Protocol 12-181] 		Tallman, Martin, MD
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
[Protocol 06-138] 		Brentjens, Renier, MD, PhD
A Phase I Study of IPI-145 in Patients with Advanced Hematologic Cancers
[Protocol 12-088] 		Horwitz, Steven, MD
A Phase I Study of Tigecycline in Patients with Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-148] 		Tallman, Martin, MD
A Phase I Trial of B-Cell Acute Lymphoblastic Leukemia Treated with Autologous T Cells Gene-Targeted to the B-Cell Antigen CD19
[Protocol 09-114] 		Davila, Marco, MD, PhD
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
[Protocol 05-103] 		Gerecitano, John, MD, PhD
A Phase I/II Study of Eltrombopag During Consolidation Therapy in Adults with Acute Myeloid Leukemia in Complete Remission
[Protocol 12-229] 		Tallman, Martin, MD
A Phase I/II Study of EPOCH Chemotherapy, Bortezomib, and Raltegravir for the Treatment of HTLV-1-Associated T-Cell Leukemia/Lymphoma
[Protocol 12-146] 		Noy, Ariela, MD
A Phase I/II Study of Low-Dose Cytarabine and Lintuzumab-Ac-225 in Older Patients with Previously Untreated Acute Myeloid Leukemia
[Protocol 09-053] 		Park, Jae, MD
A Phase II Study of AUY922 in Patients with Myelofibrosis
[Protocol 12-076] 		Rampal, Raajit, MD
A Phase II Study of Blinatumomab in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-069] 		Douer, Dan, MD
A Phase II Study of Palifermin with or without Leuprolide After T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-077] 		Goldberg, Jenna, MD
A Phase II Study of Quizartinib in Patients with FLT3-ITD-Positive Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-106] 		Tallman, Martin, MD
A Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High-Risk Chronic Lymphocytic Leukemia
[Protocol 11-024] 		Perales, Miguel-Angel, MD
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040] 		Park, Jae, MD
A Phase II Study of Vemurafenib in Patients with Relapsed or Refractory Hairy Cell Leukemia
[Protocol 12-200] 		Park, Jae, MD
A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143] 		Maslak, Peter, MD
A Phase IIB Study of 5-Azacitidine with or without Panobinostat in Patients with Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
[Protocol 12-219] 		Klimek, Virginia, MD
A Phase III Study of Clofarabine versus Standard Therapy for Newly Diagnosed Acute Myeloid Leukemia in Older Adults
[Protocol 12-059] 		Tallman, Martin, MD
A Phase III Study of Cytarabine with or without Vosaroxin in Patients with First Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 11-094] 		Klimek, Virginia, MD
A Phase III Study of Elacytarabine versus Investigator's Choice in Patients with Late-Stage Acute Myeloid Leukemia
[Protocol 10-113] 		Douer, Dan, MD
A Phase III Study of Lenalidomide Alone and in Combination with Epoetin Alfa in Patients with Myelodysplastic Syndromes and Symptomatic Anemia
[Protocol 10-128] 		Klimek, Virginia, MD
A Phase III Study of Pomalidomide versus Placebo in Patients with Myeloproliferative Neoplasm-Associated Myelofibrosis Who Are Dependent on Red Blood Cell Transfusions
[Protocol 11-025] 		Rampal, Raajit, MD
A Phase III Study of Ponatinib versus Imatinib for Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
[Protocol 12-216] 		Berman, Ellin, MD
A Phase III Study of Rituximab plus GS-1101 (CAL-101) or Placebo for Previously Treated Chronic Lymphocytic Leukemia
[Protocol 12-160] 		Zelenetz, Andrew, MD, PhD
A Phase III Study of Sapacitabine in Elderly Patients Newly Diagnosed with Acute Myeloid Leukemia
[Protocol 12-034] 		Berman, Ellin, MD
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia
[Protocol 08-087] 		Barker, Juliet, MBBS
A Study of Posaconazole Versus Micafungin to Protect Against Invasive Fungal Infections in Patients Undergoing Chemotherapy for Acute Myelogenous Leukemia or Myelodysplastic Syndrome
[Protocol 10-038] 		Papanicolaou, Genovefa, MD
Recommended Links

Making an Appointment

Contact our Physician Referral Service to schedule a consultation with a Memorial Sloan-Kettering physician in Manhattan or at one of our suburban regional cancer centers.

Learn more »

Other Useful Information